No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CDRE240517P35000Β
- 1.60
- 0.000.00%
15min DelayTrading May 7 15:48 ET
0.00High0.00Low
0.00Open1.60Pre Close0 Volume10 Open Interest35.00Strike Price0.00Turnover78.72%IV-1.63%PremiumMay 17, 2024Expiry Date4.30Intrinsic Value100Multiplier9DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type-0.8124Delta0.0693Gamma6.40Leverage Ratio-0.0522Theta-0.0063Rho-5.20Eff Leverage0.0135Vega
Intraday
- 5D
- 1D
News
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
GainersiSun (NASDAQ:ISUN) stock moved upwards by 68.0% to $0.22 during Wednesday's pre-market session. Innodata (NASDAQ:INOD) stock moved upwards by 29.82% to $8.75. The company's market cap stands at
Top 3 Industrial Stocks That May Rocket Higher This Quarter
The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Cadre Holdings: A Buy Rating Despite EPS Miss, Solid Revenue and EBITDA Outlook Reinforce Growth Potential
Cadre Holdings Inc (CDRE) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
Express News | Cadre Holdings Inc - Reaffirms 2024 Full-Year Guidance
Express News | Cadre Sees FY24 Net Sales $553M-$572M Vs $565M Estimate
Comments
Cadre Holdings' performance is considered good, with efficient reinvestment of its profits leading to substantial earnings growth. Analyst forecasts suggest that the company's earnings will continue to expand in the future.
Is Cadre Holdings, Inc.'s (NYSE:CDRE) Recent Stock Performance Tethered To Its Strong Fundamentals?Robust stock performance of Cadre Holdings indicates solid fundamentals despite pricier stock. The consistent ROCE and ability to reinvest optimistically merit further research.
Insiders selling shares at Cadre Holdings could indicate a belief of overvaluation. Lack of insider purchases within a year might worry investors. However, high insider ownership might be comforting, showing a possible alignment of interests with shareholders.
Gainers:
In reaction to earnings/guidance:
β’ $Payoneer Global(PAYO.US$ +19.4%, $Toast(TOST.US$ +13.1%, $PDF Solutions(PDFS.US$ +7.7%, $Wheels Up Experience(UP.US$ +7.1%, $LegalZoom(LZ.US$ +6.5%, $Joby Aviation(JOBY.US$ +3.6%, $indie Semiconductor(INDI.US$ +2.9%, $Rocket Lab(RKLB.US$ +2.4%, $Rivian Automotive(RIVN.US$ +1.2%
Other news:
β’ $WeTrade Group(WETG.US$ +47.8%(announces $50 million sales of monkeypox virus test kits to Par...
In reaction to earnings/guidance:
β’ $Payoneer Global(PAYO.US$ +19.4%, $Toast(TOST.US$ +13.1%, $PDF Solutions(PDFS.US$ +7.7%, $Wheels Up Experience(UP.US$ +7.1%, $LegalZoom(LZ.US$ +6.5%, $Joby Aviation(JOBY.US$ +3.6%, $indie Semiconductor(INDI.US$ +2.9%, $Rocket Lab(RKLB.US$ +2.4%, $Rivian Automotive(RIVN.US$ +1.2%
Other news:
β’ $WeTrade Group(WETG.US$ +47.8%(announces $50 million sales of monkeypox virus test kits to Par...
16
2
Gainers:
β’ $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
β’ $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
β’ $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
β’ $BeiGene(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
β’ $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
β’ $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
β’ $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
β’ $BeiGene(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
17
7
Read more